ECMO Treats Acute Respiratory and Cardiopulmonary Failure
|
By HospiMedica International staff writers Posted on 03 Mar 2020 |
|
Image: The Novalung extracorporeal membrane oxygenation (ECMO) system (Photo courtesy of FMCNA)
An innovative heart and lung support system permits long-term acute respiratory or cardiopulmonary failure treatment.
The Fresenius Medical Care North America (FMCNA; Waltham, MA, USA) Novalung extracorporeal membrane oxygenation (ECMO) system is designed to provide long-term (over six hours) respiratory and/or cardiopulmonary support in order to assist physiologic gas exchange (oxygenation and CO2 removal) and extracorporeal circulation of the blood in adults with acute respiratory failure, acute cardiopulmonary failure, or both, and in situations where other treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent.
The system consists of the Novalung console panel, power supply, sensor box, and the pump drive, and is designed to power and monitor operation of the blood pump head in the extracorporeal circuit. A touchscreen monitor displays all data, parameters, and values. System parameters can be selected and adjusted by pressing the touchscreen, as well as by using the control panel function keys and the center knob. The sensor box allows data to be transferred to the console and displayed on the control panel, with connectors for pressure sensors that connect to the XLung kit tubing set and a flow sensor.
The XLung kit contains a disposable tubing set and various accessories, such as a gas line, a priming line, stopcocks, luer caps, a Christmas tree connector, tubing clamps, and cable ties. The tubing set comes pre-connected to the hollow fiber membrane oxygenator and the blood pump head, which forms an extracorporeal circuit. The XLung kit tubing has three integrated pressure sensors that connect to the sensor box, which detect air bubbles in the extracorporeal circuit and measure blood flow in a range of 1–7 Liters per minute.
“Novalung is a critical leap forward in providing heart and lung support therapy for a longer duration than ever available before,” said Mark Costanzo, president of the technologies and pharmaceuticals division of FMCNA. “We've applied our leadership and technical expertise in renal medical devices to elevate standards for acute respiratory and cardiopulmonary failure treatments and technologies. We're proud to broaden our care offerings to provide new therapies for patients with acute cardiopulmonary conditions.”
ECMO is a form of veno-venous extracorporeal life support (VV ECLS), an emerging therapy designed to provide a higher level of life support by infusing oxygen directly into the blood using an oxygenator that acts as an artificial lung. A tapered cannula provides omni-directional flow, optimizing gas exchange and reducing stress on the right side of the heart.
Related Links:
Fresenius Medical Care North America
The Fresenius Medical Care North America (FMCNA; Waltham, MA, USA) Novalung extracorporeal membrane oxygenation (ECMO) system is designed to provide long-term (over six hours) respiratory and/or cardiopulmonary support in order to assist physiologic gas exchange (oxygenation and CO2 removal) and extracorporeal circulation of the blood in adults with acute respiratory failure, acute cardiopulmonary failure, or both, and in situations where other treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent.
The system consists of the Novalung console panel, power supply, sensor box, and the pump drive, and is designed to power and monitor operation of the blood pump head in the extracorporeal circuit. A touchscreen monitor displays all data, parameters, and values. System parameters can be selected and adjusted by pressing the touchscreen, as well as by using the control panel function keys and the center knob. The sensor box allows data to be transferred to the console and displayed on the control panel, with connectors for pressure sensors that connect to the XLung kit tubing set and a flow sensor.
The XLung kit contains a disposable tubing set and various accessories, such as a gas line, a priming line, stopcocks, luer caps, a Christmas tree connector, tubing clamps, and cable ties. The tubing set comes pre-connected to the hollow fiber membrane oxygenator and the blood pump head, which forms an extracorporeal circuit. The XLung kit tubing has three integrated pressure sensors that connect to the sensor box, which detect air bubbles in the extracorporeal circuit and measure blood flow in a range of 1–7 Liters per minute.
“Novalung is a critical leap forward in providing heart and lung support therapy for a longer duration than ever available before,” said Mark Costanzo, president of the technologies and pharmaceuticals division of FMCNA. “We've applied our leadership and technical expertise in renal medical devices to elevate standards for acute respiratory and cardiopulmonary failure treatments and technologies. We're proud to broaden our care offerings to provide new therapies for patients with acute cardiopulmonary conditions.”
ECMO is a form of veno-venous extracorporeal life support (VV ECLS), an emerging therapy designed to provide a higher level of life support by infusing oxygen directly into the blood using an oxygenator that acts as an artificial lung. A tapered cannula provides omni-directional flow, optimizing gas exchange and reducing stress on the right side of the heart.
Related Links:
Fresenius Medical Care North America
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
Glucose Meter
StatStrip®
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
